mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |